CA2762071A1 - Methods and apparatus for sub-retinal catheterization - Google Patents
Methods and apparatus for sub-retinal catheterization Download PDFInfo
- Publication number
- CA2762071A1 CA2762071A1 CA2762071A CA2762071A CA2762071A1 CA 2762071 A1 CA2762071 A1 CA 2762071A1 CA 2762071 A CA2762071 A CA 2762071A CA 2762071 A CA2762071 A CA 2762071A CA 2762071 A1 CA2762071 A1 CA 2762071A1
- Authority
- CA
- Canada
- Prior art keywords
- catheter
- tip
- sub
- eye
- retinal space
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims abstract description 37
- 210000001525 retina Anatomy 0.000 claims abstract description 60
- 210000003161 choroid Anatomy 0.000 claims abstract description 41
- 206010025421 Macule Diseases 0.000 claims abstract description 15
- 239000000126 substance Substances 0.000 claims abstract description 11
- 230000001225 therapeutic effect Effects 0.000 claims abstract description 5
- 238000013459 approach Methods 0.000 claims description 18
- 230000002093 peripheral effect Effects 0.000 claims description 16
- 238000005452 bending Methods 0.000 claims description 13
- 208000014674 injury Diseases 0.000 claims description 10
- 210000003786 sclera Anatomy 0.000 claims description 10
- 230000008733 trauma Effects 0.000 claims description 10
- 230000004044 response Effects 0.000 claims description 8
- 238000002224 dissection Methods 0.000 claims description 6
- 229940006076 viscoelastic substance Drugs 0.000 claims description 6
- 239000003190 viscoelastic substance Substances 0.000 claims description 6
- 239000000835 fiber Substances 0.000 claims description 5
- 238000003780 insertion Methods 0.000 claims description 5
- 230000037431 insertion Effects 0.000 claims description 5
- 208000024304 Choroidal Effusions Diseases 0.000 claims description 3
- 238000007789 sealing Methods 0.000 claims description 3
- 230000001953 sensory effect Effects 0.000 abstract description 7
- 238000002560 therapeutic procedure Methods 0.000 abstract description 3
- 210000001508 eye Anatomy 0.000 description 27
- 210000001519 tissue Anatomy 0.000 description 26
- 239000012530 fluid Substances 0.000 description 12
- 239000004642 Polyimide Substances 0.000 description 11
- 229920001721 polyimide Polymers 0.000 description 11
- 229910001000 nickel titanium Inorganic materials 0.000 description 10
- 210000003583 retinal pigment epithelium Anatomy 0.000 description 10
- 239000000523 sample Substances 0.000 description 10
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 9
- 230000002207 retinal effect Effects 0.000 description 9
- 229910001220 stainless steel Inorganic materials 0.000 description 9
- 239000010935 stainless steel Substances 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 238000011282 treatment Methods 0.000 description 8
- 229910052751 metal Inorganic materials 0.000 description 7
- 239000002184 metal Substances 0.000 description 7
- 206010016717 Fistula Diseases 0.000 description 6
- 241000283973 Oryctolagus cuniculus Species 0.000 description 6
- 229920002614 Polyether block amide Polymers 0.000 description 6
- 230000003890 fistula Effects 0.000 description 6
- 230000035515 penetration Effects 0.000 description 6
- -1 polysiloxanes Polymers 0.000 description 6
- 239000000463 material Substances 0.000 description 5
- 238000012800 visualization Methods 0.000 description 5
- 208000002352 blister Diseases 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 4
- 201000004569 Blindness Diseases 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 239000003124 biologic agent Substances 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 238000004891 communication Methods 0.000 description 3
- 210000000795 conjunctiva Anatomy 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 3
- 229940089982 healon Drugs 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 238000001802 infusion Methods 0.000 description 3
- 150000002739 metals Chemical class 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- 230000007704 transition Effects 0.000 description 3
- 239000010963 304 stainless steel Substances 0.000 description 2
- 241001631457 Cannula Species 0.000 description 2
- 239000004696 Poly ether ether ketone Substances 0.000 description 2
- 239000004952 Polyamide Substances 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 206010038848 Retinal detachment Diseases 0.000 description 2
- 229910000589 SAE 304 stainless steel Inorganic materials 0.000 description 2
- 229910000831 Steel Inorganic materials 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 230000006835 compression Effects 0.000 description 2
- 238000007906 compression Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 239000004811 fluoropolymer Substances 0.000 description 2
- 229920002313 fluoropolymer Polymers 0.000 description 2
- 239000007943 implant Substances 0.000 description 2
- 238000012014 optical coherence tomography Methods 0.000 description 2
- 230000000149 penetrating effect Effects 0.000 description 2
- 239000008177 pharmaceutical agent Substances 0.000 description 2
- 238000013001 point bending Methods 0.000 description 2
- 229920002647 polyamide Polymers 0.000 description 2
- 229920002530 polyetherether ketone Polymers 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 230000004264 retinal detachment Effects 0.000 description 2
- 239000010959 steel Substances 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 230000005945 translocation Effects 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- 230000004393 visual impairment Effects 0.000 description 2
- BCNXQFASJTYKDJ-UHFFFAOYSA-N 1,1,2,2,3,3,4,4,5-nonafluoro-5-(trifluoromethyl)cyclopentane Chemical compound FC(F)(F)C1(F)C(F)(F)C(F)(F)C(F)(F)C1(F)F BCNXQFASJTYKDJ-UHFFFAOYSA-N 0.000 description 1
- 206010012689 Diabetic retinopathy Diseases 0.000 description 1
- 208000001351 Epiretinal Membrane Diseases 0.000 description 1
- 206010015548 Euthanasia Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 208000003098 Ganglion Cysts Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 208000002367 Retinal Perforations Diseases 0.000 description 1
- 208000017442 Retinal disease Diseases 0.000 description 1
- 208000007014 Retinitis pigmentosa Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 208000027073 Stargardt disease Diseases 0.000 description 1
- 208000005400 Synovial Cyst Diseases 0.000 description 1
- 206010058990 Venous occlusion Diseases 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 206010064930 age-related macular degeneration Diseases 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000004240 ciliary body Anatomy 0.000 description 1
- 230000004456 color vision Effects 0.000 description 1
- 238000012669 compression test Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 206010014801 endophthalmitis Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 229920005570 flexible polymer Polymers 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 239000000976 ink Substances 0.000 description 1
- 238000013152 interventional procedure Methods 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 208000018769 loss of vision Diseases 0.000 description 1
- 231100000864 loss of vision Toxicity 0.000 description 1
- 208000002780 macular degeneration Diseases 0.000 description 1
- 208000029233 macular holes Diseases 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000001328 optic nerve Anatomy 0.000 description 1
- 108091008695 photoreceptors Proteins 0.000 description 1
- 239000013308 plastic optical fiber Substances 0.000 description 1
- 229920002492 poly(sulfone) Polymers 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000007425 progressive decline Effects 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 230000001179 pupillary effect Effects 0.000 description 1
- 238000011555 rabbit model Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000037390 scarring Effects 0.000 description 1
- 239000000565 sealant Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 239000010937 tungsten Substances 0.000 description 1
- 238000012285 ultrasound imaging Methods 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/00727—Apparatus for retinal reattachment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/008—Methods or devices for eye surgery using laser
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Vascular Medicine (AREA)
- Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Biophysics (AREA)
- Pulmonology (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Materials For Medical Uses (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17888209P | 2009-05-15 | 2009-05-15 | |
| US61/178,882 | 2009-05-15 | ||
| PCT/US2010/034873 WO2010132751A1 (en) | 2009-05-15 | 2010-05-14 | Methods and apparatus for sub-retinal catheterization |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2762071A1 true CA2762071A1 (en) | 2010-11-18 |
Family
ID=43085342
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2762071A Abandoned CA2762071A1 (en) | 2009-05-15 | 2010-05-14 | Methods and apparatus for sub-retinal catheterization |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20120191064A1 (enExample) |
| EP (1) | EP2429607A4 (enExample) |
| JP (1) | JP2012526637A (enExample) |
| KR (1) | KR20120018353A (enExample) |
| CN (1) | CN102458509B (enExample) |
| AU (1) | AU2010248912A1 (enExample) |
| BR (1) | BRPI1010657A2 (enExample) |
| CA (1) | CA2762071A1 (enExample) |
| RU (1) | RU2011147332A (enExample) |
| SG (1) | SG176067A1 (enExample) |
| WO (1) | WO2010132751A1 (enExample) |
Families Citing this family (66)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070202186A1 (en) | 2006-02-22 | 2007-08-30 | Iscience Interventional Corporation | Apparatus and formulations for suprachoroidal drug delivery |
| US8197435B2 (en) | 2006-05-02 | 2012-06-12 | Emory University | Methods and devices for drug delivery to ocular tissue using microneedle |
| US7909789B2 (en) | 2006-06-26 | 2011-03-22 | Sight Sciences, Inc. | Intraocular implants and methods and kits therefor |
| US20170360609A9 (en) | 2007-09-24 | 2017-12-21 | Ivantis, Inc. | Methods and devices for increasing aqueous humor outflow |
| US8808222B2 (en) | 2007-11-20 | 2014-08-19 | Ivantis, Inc. | Methods and apparatus for delivering ocular implants into the eye |
| CA2745884C (en) | 2008-12-05 | 2017-08-01 | Ivantis, Inc. | Cannula for ocular implant delivery system |
| AU2010271218B2 (en) | 2009-07-09 | 2017-02-02 | Alcon Inc. | Ocular implants and methods for delivering ocular implants into the eye |
| CN102481171B (zh) | 2009-07-09 | 2015-01-28 | 伊万提斯公司 | 用于输送眼部植入物的单人操作装置 |
| CA2778452A1 (en) | 2009-10-23 | 2011-04-28 | Ivantis, Inc. | Ocular implant system and method |
| EP2531138B1 (en) | 2010-02-05 | 2016-11-30 | Sight Sciences, Inc. | Intraocular implants and related kits and methods |
| WO2011163505A1 (en) | 2010-06-23 | 2011-12-29 | Ivantis, Inc. | Ocular implants deployed in schlemm's canal of the eye |
| EP3520749A1 (en) | 2010-10-15 | 2019-08-07 | Clearside Biomedical, Inc. | Device for ocular access |
| JP5717182B2 (ja) * | 2011-02-25 | 2015-05-13 | Hoya株式会社 | 眼科手術器具 |
| US8657776B2 (en) | 2011-06-14 | 2014-02-25 | Ivantis, Inc. | Ocular implants for delivery into the eye |
| US8663150B2 (en) | 2011-12-19 | 2014-03-04 | Ivantis, Inc. | Delivering ocular implants into the eye |
| EP4302734A3 (en) | 2012-03-20 | 2024-03-20 | Sight Sciences, Inc. | Ocular delivery systems and methods |
| US9358156B2 (en) | 2012-04-18 | 2016-06-07 | Invantis, Inc. | Ocular implants for delivery into an anterior chamber of the eye |
| ES3023054T3 (en) | 2012-11-08 | 2025-05-29 | Clearside Biomedical Inc | Methods for the treatment of ocular disease in human subjects |
| US11400261B2 (en) | 2012-11-21 | 2022-08-02 | Concert Medical, Llc | Preformed guidewire |
| US10617558B2 (en) | 2012-11-28 | 2020-04-14 | Ivantis, Inc. | Apparatus for delivering ocular implants into an anterior chamber of the eye |
| KR102282973B1 (ko) | 2013-05-03 | 2021-07-27 | 클리어사이드 바이오메디컬, 인코포레이드 | 안구용 주사를 위한 장치 및 방법 |
| US10188550B2 (en) | 2013-06-03 | 2019-01-29 | Clearside Biomedical, Inc. | Apparatus and methods for drug delivery using multiple reservoirs |
| EP3027150B1 (en) * | 2013-08-02 | 2023-12-13 | Tel Hashomer Medical Research Infrastructure and Services Ltd. | A device for delivery of compositions to the eye |
| US10010447B2 (en) * | 2013-12-18 | 2018-07-03 | Novartis Ag | Systems and methods for subretinal delivery of therapeutic agents |
| US9730834B2 (en) | 2013-12-20 | 2017-08-15 | Novartis Ag | Variable stiffness cannula and methods for a surgical system |
| JP5777074B2 (ja) * | 2013-12-24 | 2015-09-09 | 公立大学法人横浜市立大学 | 注射針 |
| EP4555981A3 (en) * | 2014-02-12 | 2025-08-06 | Genentech, Inc. | Method and apparatus for suprachoroidal administration of therapeutic agent |
| US9925088B2 (en) * | 2014-06-06 | 2018-03-27 | Janssen Biotech, Inc. | Sub-retinal tangential needle catheter guide and introducer |
| US9949874B2 (en) | 2014-06-06 | 2018-04-24 | Janssen Biotech, Inc. | Therapeutic agent delivery device with convergent lumen |
| EP3157598A4 (en) | 2014-06-20 | 2018-05-16 | Clearside Biomedical, Inc. | Variable diameter cannula and methods for controlling insertion depth for medicament delivery |
| US9895261B1 (en) * | 2014-07-03 | 2018-02-20 | Ahmad Bakir Tarabishy | Device and method for treating retinal detachment |
| WO2016011056A1 (en) | 2014-07-14 | 2016-01-21 | Ivantis, Inc. | Ocular implant delivery system and method |
| US10391206B2 (en) * | 2014-07-30 | 2019-08-27 | University Of Kansas | Cannula for external drainage of subretinal fluid |
| US10322028B2 (en) * | 2014-09-11 | 2019-06-18 | Orbit Biomedical Limited | Method and apparatus for sensing position between layers of an eye |
| US10219936B2 (en) | 2014-09-11 | 2019-03-05 | Orbit Biomedical Limited | Therapeutic agent delivery device with advanceable cannula and needle |
| US10258502B2 (en) | 2014-09-18 | 2019-04-16 | Orbit Biomedical Limited | Therapeutic agent delivery device |
| USD750223S1 (en) | 2014-10-14 | 2016-02-23 | Clearside Biomedical, Inc. | Medical injector for ocular injection |
| US10299958B2 (en) | 2015-03-31 | 2019-05-28 | Sight Sciences, Inc. | Ocular delivery systems and methods |
| US10507134B2 (en) * | 2015-05-27 | 2019-12-17 | Novartis Ag | Systems and methods for pulsed posterior vitreous detachment creation |
| CN108135470B (zh) | 2015-08-14 | 2021-03-09 | 伊万提斯公司 | 具有压力传感器和输送系统的眼部植入物 |
| CA3006032A1 (en) * | 2015-12-14 | 2017-06-22 | Novartis Ag | Patch for sealing retinal breaks and associated devices, systems, and methods |
| US11938058B2 (en) | 2015-12-15 | 2024-03-26 | Alcon Inc. | Ocular implant and delivery system |
| EP3413851B1 (en) | 2016-02-10 | 2023-09-27 | Clearside Biomedical, Inc. | Packaging |
| US10478553B2 (en) | 2016-03-09 | 2019-11-19 | Orbit Biomedical Limited | Apparatus for subretinal administration of therapeutic agent via a curved needle |
| EP3452165A1 (en) | 2016-05-02 | 2019-03-13 | Clearside Biomedical, Inc. | Systems and methods for ocular drug delivery |
| US11000410B2 (en) | 2016-06-17 | 2021-05-11 | Gyroscope Therapeutics Limited | Guide apparatus for tangential entry into suprachoroidal space |
| US10806629B2 (en) | 2016-06-17 | 2020-10-20 | Gyroscope Therapeutics Limited | Injection device for subretinal delivery of therapeutic agent |
| US10646374B2 (en) | 2016-06-17 | 2020-05-12 | Orbit Biomedical Limited | Apparatus and method to form entry bleb for subretinal delivery of therapeutic agent |
| US20180042768A1 (en) * | 2016-08-10 | 2018-02-15 | Novartis Ag | Subretinal fluid drainage instruments, systems, and methods |
| US10973681B2 (en) | 2016-08-12 | 2021-04-13 | Clearside Biomedical, Inc. | Devices and methods for adjusting the insertion depth of a needle for medicament delivery |
| WO2018057871A1 (en) * | 2016-09-23 | 2018-03-29 | The Regents Of The University Of California | Surgical device for ab-externo sub-retinal fluid drainage |
| EP3554435B1 (en) * | 2016-12-15 | 2025-06-04 | Clearside Biomedical, Inc. | Systems for delivering drugs to retinal tissue |
| US11273072B2 (en) * | 2017-01-13 | 2022-03-15 | Gyroscope Therapeutics Limited | Suprachoroidal injection device |
| US11076984B2 (en) | 2017-03-13 | 2021-08-03 | Gyroscope Therapeutics Limited | Method of performing subretinal drainage and agent delivery |
| US12090294B2 (en) | 2017-05-02 | 2024-09-17 | Georgia Tech Research Corporation | Targeted drug delivery methods using a microneedle |
| JP7309624B2 (ja) * | 2017-06-13 | 2023-07-18 | インフォーカス，インコーポレイテッド | 緑内障の治療のためのシステム、方法及び器具 |
| WO2019008459A1 (en) * | 2017-07-06 | 2019-01-10 | Novartis Ag | METAL WIRE FOR OPTICAL FIBER CABLE AND CABLE CLAMP |
| EP3755287B1 (en) | 2018-02-22 | 2024-04-03 | Alcon Inc. | Ocular implant |
| CN108685638A (zh) * | 2018-05-08 | 2018-10-23 | 天津优视眼科技术有限公司 | 一种眼科光纤导管头端 |
| US10322030B1 (en) * | 2018-11-13 | 2019-06-18 | Khalid Al Sabti | Infusion cannula system for pars plana vitrectomy |
| US11759355B1 (en) * | 2019-02-26 | 2023-09-19 | Gyroscope Therapeutics Limited | Method of delivering leading blebs and agent to subretinal space |
| US11504270B1 (en) | 2019-09-27 | 2022-11-22 | Sight Sciences, Inc. | Ocular delivery systems and methods |
| AU2021402258A1 (en) * | 2020-12-18 | 2023-06-22 | Alcon Inc. | Ophthalmic probe assembly with flat wall tube |
| US11540940B2 (en) | 2021-01-11 | 2023-01-03 | Alcon Inc. | Systems and methods for viscoelastic delivery |
| CA3231671A1 (en) | 2021-09-10 | 2023-03-16 | Iantrek, Inc. | Methods and devices for increasing aqueous drainage of the eye |
| US20260000538A1 (en) * | 2022-01-12 | 2026-01-01 | Riken | Tissue transplantation resin tip, tissue transplantation device, retina tissue transplantation method, and retina tissue transplantation kit |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5527292A (en) * | 1990-10-29 | 1996-06-18 | Scimed Life Systems, Inc. | Intravascular device for coronary heart treatment |
| US6309374B1 (en) * | 1998-08-03 | 2001-10-30 | Insite Vision Incorporated | Injection apparatus and method of using same |
| US7485113B2 (en) * | 2001-06-22 | 2009-02-03 | Johns Hopkins University | Method for drug delivery through the vitreous humor |
| US7717899B2 (en) * | 2002-01-28 | 2010-05-18 | Cardiac Pacemakers, Inc. | Inner and outer telescoping catheter delivery system |
| US6999809B2 (en) * | 2002-07-16 | 2006-02-14 | Edwards Lifesciences Corporation | Central venous catheter having a soft tip and fiber optics |
| PT2248494E (pt) * | 2004-01-23 | 2013-08-23 | Iscience Interventional Corp | Microcânula oftálmica compósita |
| WO2005107845A1 (en) * | 2004-04-29 | 2005-11-17 | Iscience Interventional Corporation | Apparatus and method for ocular treatment |
| KR20070033974A (ko) * | 2004-04-29 | 2007-03-27 | 아이싸이언스 인터벤셔날 코포레이션 | 방수 배출의 외과적 강화를 위한 장치와 방법 |
| US20080058704A1 (en) * | 2004-04-29 | 2008-03-06 | Michael Hee | Apparatus and Method for Ocular Treatment |
| CN101128171A (zh) * | 2004-12-16 | 2008-02-20 | I科学干预公司 | 治疗青光眼的眼用植入物 |
| US9084662B2 (en) * | 2006-01-17 | 2015-07-21 | Transcend Medical, Inc. | Drug delivery treatment device |
| US20070202186A1 (en) * | 2006-02-22 | 2007-08-30 | Iscience Interventional Corporation | Apparatus and formulations for suprachoroidal drug delivery |
-
2010
- 2010-05-14 JP JP2012511039A patent/JP2012526637A/ja active Pending
- 2010-05-14 WO PCT/US2010/034873 patent/WO2010132751A1/en not_active Ceased
- 2010-05-14 BR BRPI1010657A patent/BRPI1010657A2/pt not_active Application Discontinuation
- 2010-05-14 SG SG2011083938A patent/SG176067A1/en unknown
- 2010-05-14 US US13/320,218 patent/US20120191064A1/en not_active Abandoned
- 2010-05-14 CN CN201080032398.7A patent/CN102458509B/zh not_active Expired - Fee Related
- 2010-05-14 KR KR1020117029772A patent/KR20120018353A/ko not_active Withdrawn
- 2010-05-14 EP EP10775587.8A patent/EP2429607A4/en not_active Withdrawn
- 2010-05-14 RU RU2011147332/02A patent/RU2011147332A/ru not_active Application Discontinuation
- 2010-05-14 CA CA2762071A patent/CA2762071A1/en not_active Abandoned
- 2010-05-14 AU AU2010248912A patent/AU2010248912A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| SG176067A1 (en) | 2011-12-29 |
| EP2429607A1 (en) | 2012-03-21 |
| JP2012526637A (ja) | 2012-11-01 |
| CN102458509A (zh) | 2012-05-16 |
| AU2010248912A1 (en) | 2011-12-08 |
| CN102458509B (zh) | 2015-04-22 |
| US20120191064A1 (en) | 2012-07-26 |
| KR20120018353A (ko) | 2012-03-02 |
| BRPI1010657A2 (pt) | 2017-07-18 |
| EP2429607A4 (en) | 2014-01-08 |
| RU2011147332A (ru) | 2013-06-20 |
| WO2010132751A1 (en) | 2010-11-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102458509B (zh) | 用于视网膜下导管插入的装置 | |
| JP2023169335A (ja) | 湾曲した針を介する治療剤の網膜下投与のための装置 | |
| US20200155349A1 (en) | Devices and methods for glaucoma treatment | |
| CA2522956C (en) | Opthalmic microsurgical instruments | |
| US8491549B2 (en) | Ophthalmic microsurgical system | |
| US20040147870A1 (en) | Glaucoma treatment kit | |
| US20100173866A1 (en) | Apparatus and method for ocular treatment | |
| EP2193821A1 (en) | Apparatus for ocular treatment | |
| EP4648726A2 (en) | Dose dock for syringe | |
| Kazaykin | My Approach to Retinal |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |
Effective date: 20130514 |